Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists ...
KarXT (Karuna Therapeutics) met its primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia, the company has announced. KarXT is an oral coformulation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback